Sensible Biotechnologies

Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of he world's first cell-based design, optimisation and manufacturing platform to make pure, non-immunogenic, and highly functional messenger RNA (mRNA) to unlock the next generation of… Sensible Biotechnologies is based in Cambridge, MA and was founded in 2021. It has raised $13.8 million.

Last price · $/share
—
Implied valuation
—
Total raised
$13.8M
Last round
—
Valuation — not yet established

No valuation for Sensible Biotechnologies is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($13.8M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sensible Biotechnologies with a free account
  • ·The complete investor list: 25 names
  • ·Watch Sensible Biotechnologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Sensible Biotechnologies funding history

No rounds on record

No funding rounds for Sensible Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Sensible Biotechnologies's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Sensible Biotechnologies, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Sensible Biotechnologies

How much has Sensible Biotechnologies raised?
Sensible Biotechnologies has raised $13.8M in total funding across its recorded rounds.